Elevance Health Reports Q1 2025 Earnings with Strong EPS Growth and Revenue Increase
Elevance Health (ELV) reported Q1 2025 earnings with adjusted diluted EPS of $11.97, showing over 10% year-over-year growth. The company also saw operating revenue of $48.8 billion, up more than 15% year over year, driven by premium yield improvements and increased membership. The benefit expense ratio rose to 86.4%, up 80 basis points year over year.
Tickers: $ELV
Topics: Earnings EPS Financial Performance Membership Growth Operating Expenses Revenue Growth